James Holm
As of the Effective Date, James Holm will no longer serve as the Company’s Chief Financial Officer.
Highest-materiality recent filing
Net revenue $45.2M (+40% YoY); net income $15.7M (+103%); adjusted EBITDA $5.1M (+122%).
Cronos Group Q4 2025 net revenue $44.5M (+47% YoY); net loss $0.5M vs income $43.9M
Q4 net revenue $44.5M, up 47% YoY; full-year net revenue $146.6M, up 25% YoY.
Cronos to acquire CanAdelaar, Dutch cannabis market leader, for US$67M upfront plus earnouts
Upfront consideration of €57.5M (US$67.0M) cash, plus earnout of 0.5x normalized EBITDA in 2026 and 2027.
Cronos Group Q3 net revenue $36.3M (+6% YoY); record Adj. EBITDA of $5.7M
Net revenue $36.3M, up 6% YoY; gross profit $18.3M (50% margin) vs $3.6M (11%) a year ago.
Cronos terminates VP Controller Lloyd Wilson for cause effective Aug 29, 2025
Lloyd Wilson terminated as VP, Controller and Principal Accounting Officer for cause, effective immediately.
Cronos Q2 net revenue $33.5M (+21% YoY); adjusted EBITDA turns positive to $1.7M
Net revenue $33.5M, up 21% YoY; adjusted gross margin improved to 43% from 23%.
Cronos Group 2025 annual meeting: all director nominees elected, say-on-pay and auditor ratified
Seven director nominees elected with over 206M votes for each; broker non-votes ~53.8M.
Cronos Q1 net revenue $32.3M (+28% YoY), net income $7.7M; authorizes $50M buyback
Net revenue $32.3M (+28% YoY); net income $7.7M vs loss of $2.5M in Q1 2024.
Cronos Group appoints Anna Shlimak as CFO; James Holm departs
Anna Shlimak appointed CFO effective March 19, 2025; James Holm ceases as CFO but remains employed through April 18, 2025.
Cronos Group Q4 revenue up 27% YoY to $30.3M; reports net income of $43.9M vs prior year loss
Q4 net revenue $30.3M (+27% YoY); full-year revenue $117.6M (+35% YoY).
Cronos Group Q3 revenue up 38% to $34.3M; Spinach becomes #1 cannabis brand in Canada
Net revenue $34.3M, +38% YoY; net income $7.3M vs loss of $1.6M in Q3 2023.
Cronos Group Q2 net revenue rises 46% to $27.8M; net loss widens, Adj EBITDA improves
Net revenue $27.8M, up 46% YoY; gross profit $6.3M (+103%).
Cronos Group shareholders approve reappointment of Davidson & Company LLP as auditor
On July 19, 2024, reconvened annual meeting approved auditor appointment.
Cronos ups GrowCo credit by C$70M to C$175M, secures supply rights for Phase 2
Credit Agreement adds C$70M Term Loan B for Phase 2 cannabis facility; total facility now C$175M.
All six director nominees elected; Michael Gorenstein received 204.4M votes for, 14.4M against.
Cronos terminates sale-leaseback of Peace Naturals Campus after buyer fails condition
Agreement terminated May 28, 2024; Future Farmco Canada did not satisfy due diligence/financing condition by May 27 deadline.
Cronos Q1 revenue up 30% YoY to $25.3M; net loss narrows; guidance reaffirmed
Net revenue $25.3M (+30% YoY); gross profit $4.5M (+53%); net loss improved to $(2.5M) from $(18.0M).
Cronos enters voting agreement with Altria for 2024 annual meeting support
Altria agrees to vote its Cronos shares in favor of all company proposals at 2024 annual meeting.
Cronos Group auditor KPMG exits; will not seek re-appointment for 2024 audit
KPMG notified Cronos it will not stand for re-appointment for 2024 audit due to KPMG's decision to cease auditing cannabis companies.
Cronos Group appoints Adam Wagner as Head of Cronos Israel; Gorelik becomes Chairman
Ran Gorelik steps down as GM of Cronos Israel effective April 2, 2024; becomes Chairman through April 1, 2026.
Cronos Group Q4 net revenue up 9% YoY; net loss improves to $45M; cash balance $862M
Q4 net revenue $23.9M (+9% YoY); full-year net revenue $87.2M (+1% YoY).
As of the Effective Date, James Holm will no longer serve as the Company’s Chief Financial Officer.
Effective as of March 19, 2025 (the “Effective Date”), Cronos Group Inc. (the “Company”) has appointed Anna Shlimak, the Company’s Chief Strategy Officer, as the Company’s Chief Financial Officer.
pursuant to which Mr. Gorelik will become Chairman of Cronos Israel and will no longer serve as General Manager (Cronos Israel).
Max materiality 0.75 · Median 0.70 · Most common event earnings